These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 9027856)

  • 21. Making sense of the limb-girdle muscular dystrophies.
    Bushby KM
    Brain; 1999 Aug; 122 ( Pt 8)():1403-20. PubMed ID: 10430828
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Beta-sarcoglycan: characterization and role in limb-girdle muscular dystrophy linked to 4q12.
    Lim LE; Duclos F; Broux O; Bourg N; Sunada Y; Allamand V; Meyer J; Richard I; Moomaw C; Slaughter C
    Nat Genet; 1995 Nov; 11(3):257-65. PubMed ID: 7581448
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The limb-girdle muscular dystrophies--proposal for a new nomenclature.
    Bushby KM; Beckmann JS
    Neuromuscul Disord; 1995 Jul; 5(4):337-43. PubMed ID: 7580247
    [No Abstract]   [Full Text] [Related]  

  • 24. Disruption of heart sarcoglycan complex and severe cardiomyopathy caused by beta sarcoglycan mutations.
    Barresi R; Di Blasi C; Negri T; Brugnoni R; Vitali A; Felisari G; Salandi A; Daniel S; Cornelio F; Morandi L; Mora M
    J Med Genet; 2000 Feb; 37(2):102-7. PubMed ID: 10662809
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sarcoglycan complex: a muscular supporter of dystroglycan-dystrophin interplay?
    Matsumura K; Saito F; Yamada H; Hase A; Sunada Y; Shimizu T
    Cell Mol Biol (Noisy-le-grand); 1999 Sep; 45(6):751-62. PubMed ID: 10541473
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Extraocular muscle is spared despite the absence of an intact sarcoglycan complex in gamma- or delta-sarcoglycan-deficient mice.
    Porter JD; Merriam AP; Hack AA; Andrade FH; McNally EM
    Neuromuscul Disord; 2001 Mar; 11(2):197-207. PubMed ID: 11257478
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical heterogeneity of adhalin deficiency.
    Morandi L; Barresi R; Di Blasi C; Jung D; Sunada Y; Confalonieri V; Dworzak F; Mantegazza R; Antozzi C; Jarre L; Pini A; Gobbi G; Bianchi C; Cornelio F; Campbell KP; Mora M
    Ann Neurol; 1996 Feb; 39(2):196-202. PubMed ID: 8967751
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Molecular basis of inherited muscular diseases].
    Takeda S
    No To Shinkei; 1995 Aug; 47(8):735-48. PubMed ID: 7546918
    [No Abstract]   [Full Text] [Related]  

  • 29. Sarcoglycans in muscular dystrophy.
    Hack AA; Groh ME; McNally EM
    Microsc Res Tech; 2000 Feb 1-15; 48(3-4):167-80. PubMed ID: 10679964
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Abnormalities in alpha-, beta- and gamma-sarcoglycan in patients with limb-girdle muscular dystrophy.
    Sewry CA; Taylor J; Anderson LV; Ozawa E; Pogue R; Piccolo F; Bushby K; Dubowitz V; Muntoni F
    Neuromuscul Disord; 1996 Dec; 6(6):467-74. PubMed ID: 9027857
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Homozygous alpha-sarcoglycan mutation in two siblings: one asymptomatic and one steroid-responsive mild limb-girdle muscular dystrophy patient.
    Angelini C; Fanin M; Menegazzo E; Freda MP; Duggan DJ; Hoffman EP
    Muscle Nerve; 1998 Jun; 21(6):769-75. PubMed ID: 9585331
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The clinical spectrum of sarcoglycanopathies.
    Angelini C; Fanin M; Freda MP; Duggan DJ; Siciliano G; Hoffman EP
    Neurology; 1999 Jan; 52(1):176-9. PubMed ID: 9921870
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation of cardiac and respiratory involvement in sarcoglycanopathies.
    Politano L; Nigro V; Passamano L; Petretta V; Comi LI; Papparella S; Nigro G; Rambaldi PF; Raia P; Pini A; Mora M; Giugliano MA; Esposito MG; Nigro G
    Neuromuscul Disord; 2001 Mar; 11(2):178-85. PubMed ID: 11257475
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Genetic studies and molecular structures: the dystrophin associated complex.
    Beckmann JS
    Hum Mol Genet; 1996 Jul; 5(7):865-7. PubMed ID: 8817320
    [No Abstract]   [Full Text] [Related]  

  • 35. Primary alpha-sarcoglycan deficiency responsive to immunosuppression over three years.
    Connolly AM; Pestronk A; Mehta S; Al-Lozi M
    Muscle Nerve; 1998 Nov; 21(11):1549-53. PubMed ID: 9771686
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [The frequency of patients with adhalin deficiency in a muscular dystrophy patient population].
    Hayashi YK; Arahata K
    Nihon Rinsho; 1997 Dec; 55(12):3165-8. PubMed ID: 9436429
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Clinicopathological characteristics and molecular genetics of adhalin deficiency (severe childhood autosomal recessive muscular dystrophy/SCARMD)].
    Matsumura K
    Nihon Rinsho; 1997 Dec; 55(12):3154-8. PubMed ID: 9436427
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Primary beta-sarcoglycanopathy manifesting as recurrent exercise-induced myoglobinuria.
    Cagliani R; Comi GP; Tancredi L; Sironi M; Fortunato F; Giorda R; Bardoni A; Moggio M; Prelle A; Bresolin N; Scarlato G
    Neuromuscul Disord; 2001 May; 11(4):389-94. PubMed ID: 11369190
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Muscular dystrophy due to a deficit of gamma-sarcoglycan. A report of three patients with the Delta-521t mutation].
    Eirís-Puñal J; Pintos-Martínez E; Lasa A; Gallano P; Castro-Gago M
    Rev Neurol; 2002 Mar 1-15; 34(5):486-9. PubMed ID: 12040521
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A rare cause of high transaminasemia: autosomal muscle dystrophy with gamma sarcoglycan.
    Urganci N; Erkan T; Serdaroglu P; Oztelik G; Dogan S; Kayaalp N
    J Pediatr Gastroenterol Nutr; 2001 Mar; 32(3):327-9. PubMed ID: 11345186
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.